Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The effect of drug treatment on neurogenesis in Parkinson's disease

Identifieur interne : 001C23 ( Istex/Curation ); précédent : 001C22; suivant : 001C24

The effect of drug treatment on neurogenesis in Parkinson's disease

Auteurs : Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew J. Lees [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni]

Source :

RBID : ISTEX:20400833E0FC8F49CC3E88C9892ACBD539242333

English descriptors

Abstract

There has been recent interest in the possibility that impaired neurogenesis may contribute to the decline in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease (PD). We have investigated the effects of commonly used treatments for PD on neural stem cell (NSC) activity in nondemented patients. Postmortem of brain tissue containing the subventricular zone (SVZ) and ependymal layer cells was obtained from 32 nondemented patients with PD. NSC activity was assessed by immunohistochemical staining for RNA‐binding protein Musashi1. Regression analyses were then used to identify which clinical factors independently influenced NSC activity. Disease duration was negatively associated with SVZ Musashi1 staining, whereas lifetime levodopa was positively associated in this region. Our findings suggest a positive impact of chronic L‐dopa use on the number of NSC in the SVZ of PD patients, which may have relevance for future studies on neuroprotection in neurodegenerative diseases. © 2010 Movement Disorder Society.

Url:
DOI: 10.1002/mds.23340

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:20400833E0FC8F49CC3E88C9892ACBD539242333

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The effect of drug treatment on neurogenesis in Parkinson's disease</title>
<author>
<name sortKey="O Sullivan, Sean S" sort="O Sullivan, Sean S" uniqKey="O Sullivan S" first="Sean S." last="O'Sullivan">Sean S. O'Sullivan</name>
<affiliation wicri:level="1">
<mods:affiliation>Reta Lila Weston Institute of Neurological Studies, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, University College London, London</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Johnson, Mary" sort="Johnson, Mary" uniqKey="Johnson M" first="Mary" last="Johnson">Mary Johnson</name>
<affiliation wicri:level="1">
<mods:affiliation>Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle‐upon‐Tyne, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle‐upon‐Tyne</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Williams, David R" sort="Williams, David R" uniqKey="Williams D" first="David R." last="Williams">David R. Williams</name>
<affiliation wicri:level="1">
<mods:affiliation>Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus), Melbourne, Australia</mods:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus), Melbourne</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Revesz, Tamas" sort="Revesz, Tamas" uniqKey="Revesz T" first="Tamas" last="Revesz">Tamas Revesz</name>
<affiliation wicri:level="1">
<mods:affiliation>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Holton, Janice L" sort="Holton, Janice L" uniqKey="Holton J" first="Janice L." last="Holton">Janice L. Holton</name>
<affiliation wicri:level="1">
<mods:affiliation>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation wicri:level="1">
<mods:affiliation>Reta Lila Weston Institute of Neurological Studies, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, University College London, London</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Perry, Elaine K" sort="Perry, Elaine K" uniqKey="Perry E" first="Elaine K." last="Perry">Elaine K. Perry</name>
<affiliation wicri:level="1">
<mods:affiliation>Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle‐upon‐Tyne, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle‐upon‐Tyne</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:20400833E0FC8F49CC3E88C9892ACBD539242333</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23340</idno>
<idno type="url">https://api.istex.fr/document/20400833E0FC8F49CC3E88C9892ACBD539242333/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C23</idno>
<idno type="wicri:Area/Istex/Curation">001C23</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">The effect of drug treatment on neurogenesis in Parkinson's disease</title>
<author>
<name sortKey="O Sullivan, Sean S" sort="O Sullivan, Sean S" uniqKey="O Sullivan S" first="Sean S." last="O'Sullivan">Sean S. O'Sullivan</name>
<affiliation wicri:level="1">
<mods:affiliation>Reta Lila Weston Institute of Neurological Studies, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, University College London, London</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Johnson, Mary" sort="Johnson, Mary" uniqKey="Johnson M" first="Mary" last="Johnson">Mary Johnson</name>
<affiliation wicri:level="1">
<mods:affiliation>Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle‐upon‐Tyne, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle‐upon‐Tyne</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Williams, David R" sort="Williams, David R" uniqKey="Williams D" first="David R." last="Williams">David R. Williams</name>
<affiliation wicri:level="1">
<mods:affiliation>Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus), Melbourne, Australia</mods:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Faculty of Medicine (Neuroscience), Monash University (Alfred Hospital Campus), Melbourne</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Revesz, Tamas" sort="Revesz, Tamas" uniqKey="Revesz T" first="Tamas" last="Revesz">Tamas Revesz</name>
<affiliation wicri:level="1">
<mods:affiliation>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Holton, Janice L" sort="Holton, Janice L" uniqKey="Holton J" first="Janice L." last="Holton">Janice L. Holton</name>
<affiliation wicri:level="1">
<mods:affiliation>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation wicri:level="1">
<mods:affiliation>Reta Lila Weston Institute of Neurological Studies, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, University College London, London</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Queen Square Brain Bank for Neurological Disorders and Institute of Neurology, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Perry, Elaine K" sort="Perry, Elaine K" uniqKey="Perry E" first="Elaine K." last="Perry">Elaine K. Perry</name>
<affiliation wicri:level="1">
<mods:affiliation>Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle‐upon‐Tyne, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle‐upon‐Tyne</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-01">2011-01</date>
<biblScope unit="vol">26</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="45">45</biblScope>
<biblScope unit="page" to="50">50</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">20400833E0FC8F49CC3E88C9892ACBD539242333</idno>
<idno type="DOI">10.1002/mds.23340</idno>
<idno type="ArticleID">MDS23340</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Parkinson's disease</term>
<term>neurogenesis</term>
<term>neuroprotection</term>
<term>stem cells</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There has been recent interest in the possibility that impaired neurogenesis may contribute to the decline in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease (PD). We have investigated the effects of commonly used treatments for PD on neural stem cell (NSC) activity in nondemented patients. Postmortem of brain tissue containing the subventricular zone (SVZ) and ependymal layer cells was obtained from 32 nondemented patients with PD. NSC activity was assessed by immunohistochemical staining for RNA‐binding protein Musashi1. Regression analyses were then used to identify which clinical factors independently influenced NSC activity. Disease duration was negatively associated with SVZ Musashi1 staining, whereas lifetime levodopa was positively associated in this region. Our findings suggest a positive impact of chronic L‐dopa use on the number of NSC in the SVZ of PD patients, which may have relevance for future studies on neuroprotection in neurodegenerative diseases. © 2010 Movement Disorder Society.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C23 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001C23 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:20400833E0FC8F49CC3E88C9892ACBD539242333
   |texte=   The effect of drug treatment on neurogenesis in Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024